At a glance
ClinicalIndex Comparison RecordN/ACompleted· 193 enrolled
Drug / intervention
Spiriva Respimatdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Specific Use-Result Surveillance of Spiriva Respimat in Asthmatics (Patients With Mild and Moderate Persistent Asthma)
In Brief
An observational study evaluating Spiriva Respimat for Asthma. Completed, enrolled 193 participants across 1 site.
Detailed Summary
The study objective is to investigate the safety and effectiveness of Spiriva Respimat in patients with mild to moderate persistent asthma under real-world use
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartJul 2017
Primary CompletionSep 2018
Study CompletionNov 2018
TodayJul 2026
First PostedJun 15, 2017
Enrollment StartJul 4, 2017
Primary CompletionSep 22, 2018
Study CompletionNov 8, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.0 years ago
Interventions
Spiriva Respimatdrug
Drug